AZN

AstraZeneca PLC
67.92
0.66 (0.98%)

AstraZeneca PLC (AZN) Fundamentals

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
SHARE INFORMATION
Market CapUS$ 206,344,830,459
Shares Outstanding3,099,666,974
Float3,097,559,642
Percent Float99.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 1.45
Latest Fiscal RevenueUS$ 45,157,520,247
Latest Fiscal EPSUS$ 1.06
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 1.06
Dividend (5 Years)US$ 0.50
Ex Dividend Date2023-02-23
Dividend RateUS$ 1.93
Dividend Yield2.9%
Payment CashCash
HOLDERS
Institutions1,726
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months43,078,116
Institutional Holdings Percent30.1%
Institutional Sold Previous 3 Months80,622,836
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months37,382
Insider Holdings Percent0.1
Insider Sold Previous 3 Months300
Insider Shares Owned2,107,332
TRADING INFO
52 Week HighUS$ 72.12
52 Week LowUS$ 52.65
52 Week High ChangeUS$ 6.79
21 Day Moving AverageUS$ 65.5783
21 Day Extended Moving AverageUS$ 65.9186
50 Day Moving AverageUS$ 66.2447
50 Day Extended Moving AverageUS$ 66.2652
200 Day Moving AverageUS$ 63.3115
200 Day Extended Moving AverageUS$ 64.5606
10 Day Average Volume4,866,151
20 Day Average Volume4,266,379
30 Day Average Volume4,541,942
50 Day Average Volume5,228,302
Alpha0.011505
Beta0.5060
Standard Deviation0.061834
R20.194226
7 Day Price ChangeUS$ 1.99
7 Day Percent Change3.08%
21 Day Price ChangeUS$ 1.36
21 Day Percent Change2.09%
30 Day Price ChangeUS$ -1.31
30 Day Percent Change-1.94%
Month to Date Price ChangeUS$ 1.39
Month to Date Percent Change2.13%
Quarter to Date Price ChangeUS$ -0.27972
Quarter to Date Percent Change-0.42%
180 Day Price ChangeUS$ 11.05
180 Day Percent Change19.9%
200 Day Price ChangeUS$ 6.73
200 Day Percent Change11.25%
Year to Date Price ChangeUS$ -0.27972
Year to Date Percent Change-0.42%

AstraZeneca PLC (AZN) Key Ratios

PROFITABILITY
EBIT Margin5.3%
EBITDA Margin19.0%
Pre-Tax Profit Margin6.3%
Profit Margin Count7.63%
Gross Margin72.1%
Profit Margin TOT7.63%
INCOME STATEMENTS
RevenueUS$ 42,306,768,437
Revenue Per ShareUS$ 13.6488
Revenue (3 Years)US$ 28.27
Revenue (5 Years)US$ 16.35
FINANCIAL STRENGTH
Price to Tangible Book-9.40
Total Debt To Equity0.80
Int Coverage2.90
Current Ratio0.90
Leverage Ratio2.70
Quick Ratio0.20
Long Term Debt To Capital0.39
VALUATION MEASURES
PE Ratio63.30
Enterprise ValueUS$ 228,739,063,519
Price to Sales4.8773
Price to Free Cash114.20
PE High Last 5 Years573.60
Price To Book5.60
Price To Cash Flow21.20
PE Low Last 5 Years27.60
Price to Tangible Book-9.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover1.90
Assets Turnover0.40
Return Assets3.36
Return on Equity8.88
Return on Capital4.10

AstraZeneca PLC (AZN) Profile

PROFILE INFO
Issue TypeAD
SEC TypeDR
Auditor-
CEOPascal Soriot
Emplyoees83500
Last Audit-
CIK0000901832
IndustryDrug Manufacturers
SectorHealthcare
NAICS-
CONTACT INFO
Address1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB2 0AA
Websitehttps://www.astrazeneca.com
Facsimile+44 1223352858
Telephone+44 2037495000
Emailir@astrazeneca.com
Your Recent History
NASDAQ
AZN
AstraZenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 11:19:57